APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide Delivery Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhaled Nitric Oxide Delivery Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026192 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Delivery Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Delivery Device Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Delivery Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Delivery Device Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Delivery Device Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhaled Nitric Oxide Delivery Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhaled Nitric Oxide Delivery Device include Air Liquide Healthcare, Bellerophon Therapeutics, Beyond Air, Circassia Pharmaceuticals, Getinge, LINDE, Mallinckrodt Pharmaceuticals, NU MED and Praxair Technology Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhaled Nitric Oxide Delivery Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaled Nitric Oxide Delivery Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaled Nitric Oxide Delivery Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhaled Nitric Oxide Delivery Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhaled Nitric Oxide Delivery Device Segment by Company

Air Liquide Healthcare

Bellerophon Therapeutics

Beyond Air

Circassia Pharmaceuticals

Getinge

LINDE

Mallinckrodt Pharmaceuticals

NU MED

Praxair Technology Inc.

Vero Biotech

Inhaled Nitric Oxide Delivery Device Segment by Type

Inhaled Nitric Oxide Delivery Device for Children

Inhaled Nitric Oxide Delivery Device for Adults

Inhaled Nitric Oxide Delivery Device Segment by Application

Hypoxic Respiratory Failure (HRF)

Chronic Obstructive Pulmonary Disease (COPD)

Acute Hypoxemic Respiratory Failure (AHRF)

Others

Inhaled Nitric Oxide Delivery Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Delivery Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaled Nitric Oxide Delivery Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhaled Nitric Oxide Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhaled Nitric Oxide Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhaled Nitric Oxide Delivery Device Industry Trends Table 2. Inhaled Nitric Oxide Delivery Device Industry Drivers Table 3. Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges Table 4. Inhaled Nitric Oxide Delivery Device Industry Restraints Table 5. Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers Table 9. Global Inhaled Nitric Oxide Delivery Device Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Inhaled Nitric Oxide Delivery Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhaled Nitric Oxide Delivery Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhaled Nitric Oxide Delivery Device Manufacturers, Product Type & Application Table 13. Global Inhaled Nitric Oxide Delivery Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhaled Nitric Oxide Delivery Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inhaled Nitric Oxide Delivery Device for Children Table 17. Major Manufacturers of Inhaled Nitric Oxide Delivery Device for Adults Table 18. Global Inhaled Nitric Oxide Delivery Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 20. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 21. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2026) Table 22. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2027-2032) Table 23. Global Inhaled Nitric Oxide Delivery Device Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (k units) Table 25. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (k units) Table 26. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2026) Table 27. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hypoxic Respiratory Failure (HRF) Table 29. Major Manufacturers of Chronic Obstructive Pulmonary Disease (COPD) Table 30. Major Manufacturers of Acute Hypoxemic Respiratory Failure (AHRF) Table 31. Major Manufacturers of Others Table 32. Global Inhaled Nitric Oxide Delivery Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 34. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 35. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2026) Table 36. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2027-2032) Table 37. Global Inhaled Nitric Oxide Delivery Device Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (k units) Table 39. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (k units) Table 40. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2026) Table 41. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2027-2032) Table 42. Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2026) & (k units) Table 44. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2021-2026) Table 45. Global Inhaled Nitric Oxide Delivery Device Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Inhaled Nitric Oxide Delivery Device Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 49. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 50. Europe Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 52. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 59. Global Inhaled Nitric Oxide Delivery Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2021-2026) Table 63. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2027-2032) Table 64. Air Liquide Healthcare Company Information Table 65. Air Liquide Healthcare Business Overview Table 66. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio Table 68. Air Liquide Healthcare Recent Development Table 69. Bellerophon Therapeutics Company Information Table 70. Bellerophon Therapeutics Business Overview Table 71. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio Table 73. Bellerophon Therapeutics Recent Development Table 74. Beyond Air Company Information Table 75. Beyond Air Business Overview Table 76. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio Table 78. Beyond Air Recent Development Table 79. Circassia Pharmaceuticals Company Information Table 80. Circassia Pharmaceuticals Business Overview Table 81. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio Table 83. Circassia Pharmaceuticals Recent Development Table 84. Getinge Company Information Table 85. Getinge Business Overview Table 86. Getinge Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio Table 88. Getinge Recent Development Table 89. LINDE Company Information Table 90. LINDE Business Overview Table 91. LINDE Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio Table 93. LINDE Recent Development Table 94. Mallinckrodt Pharmaceuticals Company Information Table 95. Mallinckrodt Pharmaceuticals Business Overview Table 96. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio Table 98. Mallinckrodt Pharmaceuticals Recent Development Table 99. NU MED Company Information Table 100. NU MED Business Overview Table 101. NU MED Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio Table 103. NU MED Recent Development Table 104. Praxair Technology Inc. Company Information Table 105. Praxair Technology Inc. Business Overview Table 106. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio Table 108. Praxair Technology Inc. Recent Development Table 109. Vero Biotech Company Information Table 110. Vero Biotech Business Overview Table 111. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio Table 113. Vero Biotech Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Inhaled Nitric Oxide Delivery Device Distributors List Table 117. Inhaled Nitric Oxide Delivery Device Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Delivery Device Product Image Figure 2. Global Inhaled Nitric Oxide Delivery Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Delivery Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaled Nitric Oxide Delivery Device Sales (2021-2032) & (k units) Figure 5. Global Inhaled Nitric Oxide Delivery Device Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhaled Nitric Oxide Delivery Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inhaled Nitric Oxide Delivery Device for Children Image Figure 9. Inhaled Nitric Oxide Delivery Device for Adults Image Figure 10. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Inhaled Nitric Oxide Delivery Device Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032) Figure 13. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032) Figure 16. Hypoxic Respiratory Failure (HRF) Image Figure 17. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 18. Acute Hypoxemic Respiratory Failure (AHRF) Image Figure 19. Others Image Figure 20. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Inhaled Nitric Oxide Delivery Device Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032) Figure 23. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032) Figure 26. North America Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032) Figure 28. U.S. Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032) Figure 33. Germany Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032) Figure 40. China Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032) Figure 48. Brazil Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Inhaled Nitric Oxide Delivery Device Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Inhaled Nitric Oxide Delivery Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Figure 59. North America Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Figure 61. Europe Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Inhaled Nitric Oxide Delivery Device Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Inhaled Nitric Oxide Delivery Device Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaled Nitric Oxide Delivery Device for Children
  • Inhaled Nitric Oxide Delivery Device for Adults
Applications
  • Hypoxic Respiratory Failure (HRF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Others
Companies covered
  • Air Liquide Healthcare
  • Bellerophon Therapeutics
  • Beyond Air
  • Circassia Pharmaceuticals
  • Getinge
  • LINDE
  • Mallinckrodt Pharmaceuticals
  • NU MED
  • Praxair Technology Inc.
  • Vero Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhaled Nitric Oxide Delivery Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhaled Nitric Oxide Delivery Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhaled Nitric Oxide Delivery Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhaled Nitric Oxide Delivery Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhaled Nitric Oxide Delivery Device Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Delivery Device Industry Trends
  2. 2.2 Inhaled Nitric Oxide Delivery Device Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Delivery Device Industry Restraints
3 Inhaled Nitric Oxide Delivery Device Market by Manufacturers
  1. 3.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhaled Nitric Oxide Delivery Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhaled Nitric Oxide Delivery Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhaled Nitric Oxide Delivery Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhaled Nitric Oxide Delivery Device Manufacturers, Product Type & Application
  7. 3.7 Global Inhaled Nitric Oxide Delivery Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhaled Nitric Oxide Delivery Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhaled Nitric Oxide Delivery Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhaled Nitric Oxide Delivery Device Tier 1, Tier 2, and Tier 3
4 Inhaled Nitric Oxide Delivery Device Market by Type
  1. 4.1 Inhaled Nitric Oxide Delivery Device Type Introduction
  2. 4.1.1 Inhaled Nitric Oxide Delivery Device for Children
  3. 4.1.2 Inhaled Nitric Oxide Delivery Device for Adults
  4. 4.2 Global Inhaled Nitric Oxide Delivery Device Sales by Type
  5. 4.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
  7. 4.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032)
  8. 4.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Type
  9. 4.3.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
  11. 4.3.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032)
5 Inhaled Nitric Oxide Delivery Device Market by Application
  1. 5.1 Inhaled Nitric Oxide Delivery Device Application Introduction
  2. 5.1.1 Hypoxic Respiratory Failure (HRF)
  3. 5.1.2 Chronic Obstructive Pulmonary Disease (COPD)
  4. 5.1.3 Acute Hypoxemic Respiratory Failure (AHRF)
  5. 5.1.4 Others
  6. 5.2 Global Inhaled Nitric Oxide Delivery Device Sales by Application
  7. 5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
  9. 5.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032)
  10. 5.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Application
  11. 5.3.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
  13. 5.3.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032)
6 Global Inhaled Nitric Oxide Delivery Device Sales by Region
  1. 6.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2032)
  3. 6.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2026)
  4. 6.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhaled Nitric Oxide Delivery Device Revenue by Region
  1. 7.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region
  2. 7.1.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhaled Nitric Oxide Delivery Device Revenue (2021-2032)
  8. 7.2.2 North America Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhaled Nitric Oxide Delivery Device Revenue (2021-2032)
  11. 7.3.2 Europe Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Air Liquide Healthcare
  2. 8.1.1 Air Liquide Healthcare Company Information
  3. 8.1.2 Air Liquide Healthcare Business Overview
  4. 8.1.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
  6. 8.1.5 Air Liquide Healthcare Recent Developments
  7. 8.2 Bellerophon Therapeutics
  8. 8.2.1 Bellerophon Therapeutics Company Information
  9. 8.2.2 Bellerophon Therapeutics Business Overview
  10. 8.2.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
  12. 8.2.5 Bellerophon Therapeutics Recent Developments
  13. 8.3 Beyond Air
  14. 8.3.1 Beyond Air Company Information
  15. 8.3.2 Beyond Air Business Overview
  16. 8.3.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
  18. 8.3.5 Beyond Air Recent Developments
  19. 8.4 Circassia Pharmaceuticals
  20. 8.4.1 Circassia Pharmaceuticals Company Information
  21. 8.4.2 Circassia Pharmaceuticals Business Overview
  22. 8.4.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
  24. 8.4.5 Circassia Pharmaceuticals Recent Developments
  25. 8.5 Getinge
  26. 8.5.1 Getinge Company Information
  27. 8.5.2 Getinge Business Overview
  28. 8.5.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
  30. 8.5.5 Getinge Recent Developments
  31. 8.6 LINDE
  32. 8.6.1 LINDE Company Information
  33. 8.6.2 LINDE Business Overview
  34. 8.6.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
  36. 8.6.5 LINDE Recent Developments
  37. 8.7 Mallinckrodt Pharmaceuticals
  38. 8.7.1 Mallinckrodt Pharmaceuticals Company Information
  39. 8.7.2 Mallinckrodt Pharmaceuticals Business Overview
  40. 8.7.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
  42. 8.7.5 Mallinckrodt Pharmaceuticals Recent Developments
  43. 8.8 NU MED
  44. 8.8.1 NU MED Company Information
  45. 8.8.2 NU MED Business Overview
  46. 8.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
  48. 8.8.5 NU MED Recent Developments
  49. 8.9 Praxair Technology Inc.
  50. 8.9.1 Praxair Technology Inc. Company Information
  51. 8.9.2 Praxair Technology Inc. Business Overview
  52. 8.9.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
  54. 8.9.5 Praxair Technology Inc. Recent Developments
  55. 8.10 Vero Biotech
  56. 8.10.1 Vero Biotech Company Information
  57. 8.10.2 Vero Biotech Business Overview
  58. 8.10.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
  60. 8.10.5 Vero Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhaled Nitric Oxide Delivery Device Value Chain Analysis
  2. 9.1.1 Inhaled Nitric Oxide Delivery Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhaled Nitric Oxide Delivery Device Production Mode & Process
  6. 9.2 Inhaled Nitric Oxide Delivery Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhaled Nitric Oxide Delivery Device Distributors
  9. 9.2.3 Inhaled Nitric Oxide Delivery Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst